Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Sun Pharma eyes to launch obesity drug in five years: MD Ruchika Sharma1 March 2025 2:34 PM ISTMumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes medicine in the next...
Semaglutide shows promise in reducing cravings for alcohol, heavy drinking, finds study Dr. Kamal Kant Kohli14 Feb 2025 8:15 AM ISTThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol...
Phase 2b QUALITY Trial: Enobosarm Significantly Reduces Lean Mass Loss in Patients on Semaglutide Dr. Kamal Kant Kohli31 Jan 2025 9:30 AM ISTEnobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients Farhat Nasim20 Nov 2024 1:36 PM ISTThe move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.
West Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies MD Bureau27 Oct 2024 9:45 AM ISTBengaluru: West Pharmaceutical Services raised its annual profit outlook on Thursday after exceeding Wall Street's expectations for quarterly...
Semaglutide may reduce risk of Alzheimer's disease in diabetes patients, suggests study Dr. Kamal Kant Kohli25 Oct 2024 8:00 PM ISTResearchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of...
Popular weight-loss drugs prove more costly than metabolic and bariatric surgery within one year unravels analysis Dr. Kamal Kant Kohli9 Oct 2024 8:00 PM ISTResearchers from USF Health Morsani College of Medicine in Tampa, FL compared the cumulative cost of pharmacotherapy with GLP-1 agonists to onetime...
Semaglutide associated with lower opioid overdoses in people OUD and type 2 diabetes: JAMA Dr. Kamal Kant Kohli27 Sept 2024 9:00 AM ISTSince being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the...
